$1.85
-0.06[-3.14%]
At close: Apr 15
$1.85
0[0.00%]
After Hours: 5:54PM EDT
Xeris Biopharma Holdings
(NASDAQ:XERS)Xeris Biopharma Holdings Stock (NASDAQ:XERS), Earnings Estimates, EPS, and Revenue
Xeris Biopharma Holdings reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 7
EPS Estimate
$-0.110
Quarterly Revenue Estimate
$42.3M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$163.9M
Analyze the earnings history of Xeris Biopharma Holdings using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/07/2024 | AM | XERS | Q1 | -$0.12 | -$0.11 | — | — | $33.20M | $42.33M | — | — | Get Alert |
| 03/06/2024 | AM | XERS | Q4 | -$0.10 | -$0.10 | -$0.10 | 0.00% | $33.14M | $43.55M | $44.39M | 1.93% | Get Alert |
| 11/09/2023 | AM | XERS | Q3 | -$0.16 | -$0.12 | -$0.09 | 25.00% | $29.73M | $41.08M | $48.32M | 17.62% | Get Alert |
| 08/08/2023 | AM | XERS | Q2 | -$0.19 | -$0.13 | -$0.14 | -7.69% | $25.26M | $34.84M | $36.89M | 5.89% | Get Alert |
| 05/09/2023 | AM | XERS | Q1 | -$0.25 | -$0.17 | -$0.12 | 29.41% | $22.07M | $30.76M | $33.20M | 7.92% | Get Alert |
| 03/08/2023 | AM | XERS | Q4 | -$0.42 | -$0.16 | -$0.10 | 37.50% | $21.43M | $31.04M | $33.14M | 6.78% | Get Alert |
| 11/09/2022 | AM | XERS | Q3 | -$0.39 | -$0.16 | -$0.16 | 0.00% | $11.04M | $29.12M | $29.73M | 2.08% | Get Alert |
| 08/10/2022 | AM | XERS | Q2 | -$0.41 | -$0.20 | -$0.19 | 5.00% | $8.84M | $25.53M | $25.26M | -1.06% | Get Alert |
| 05/11/2022 | AM | XERS | Q1 | -$0.30 | -$0.25 | -$0.25 | 0.00% | $8.05M | $23.59M | $21.91M | -7.12% | Get Alert |
| 03/10/2022 | AM | XERS | Q4 | -$0.41 | -$0.24 | -$0.42 | -75.00% | $7.09M | $18.90M | $21.43M | 13.38% | Get Alert |
| 11/10/2021 | AM | XERS | Q3 | -$0.35 | -$0.37 | -$0.39 | -5.41% | $9.45M | $11.03M | $11.04M | 0.05% | Get Alert |
| 08/05/2021 | AM | XERS | Q2 | -$0.63 | -$0.30 | -$0.41 | -36.67% | $2.03M | $9.54M | $8.84M | -7.39% | Get Alert |
| 05/13/2021 | AM | XERS | Q1 | -$0.89 | -$0.34 | -$0.30 | 11.76% | $1.79M | $7.47M | $8.05M | 7.78% | Get Alert |
| 03/09/2021 | AM | XERS | Q4 | -$1.23 | -$0.38 | -$0.41 | -7.89% | $1.86M | $8.21M | $7.09M | -13.65% | Get Alert |
| 11/09/2020 | AM | XERS | Q3 | -$1.22 | -$0.52 | -$0.35 | 32.69% | $314.00K | $4.48M | $9.45M | 110.89% | Get Alert |
| 08/10/2020 | AM | XERS | Q2 | -$1.28 | -$0.73 | -$0.63 | 13.70% | $320.00K | $1.86M | $2.03M | 8.98% | Get Alert |
| 05/07/2020 | AM | XERS | Q1 | -$1.07 | -$0.89 | -$0.89 | 0.00% | $248.00K | $1.43M | $1.79M | 25.03% | Get Alert |
| 03/11/2020 | AM | XERS | Q4 | -$0.98 | -$1.13 | -$1.23 | -8.85% | $801.00K | $660.00K | $1.86M | 182.42% | Get Alert |
| 11/07/2019 | AM | XERS | Q3 | -$0.71 | — | -$1.22 | — | $582.00K | — | $314.00K | — | Get Alert |
FAQ
When is Xeris Biopharma Holdings (NASDAQ:XERS) reporting earnings?
Xeris Biopharma Holdings (XERS) is scheduled to report earnings on May 7, 2024. The last reported earnings were for reported on March 6, 2024 for Q4.
What were the latest earnings per share (EPS) for Xeris Biopharma Holdings (NASDAQ:XERS)?
The Actual EPS was $-0.10, which hit the estimate of $-0.10.
What were Xeris Biopharma Holdings’s (NASDAQ:XERS) revenues?
The Actual Revenue was $44.4M, which beat the estimate of $43.5M.
Browse earnings estimates, EPS, and revenue on all stocks.